Literature DB >> 18307442

Usefulness of tricuspid annular velocity in identifying global RV dysfunction in patients with primary pulmonary hypertension: a comparison with 3D echo-derived right ventricular ejection fraction.

Stefano De Castro1, Elena Cavarretta, Alberto Milan, Stefano Caselli, Emanuele Di Angelantonio, Dario Vizza Carmine, Diego Lucchetti, Ayan Patel, Jeffrey Kuvin, Natesa G Pandian.   

Abstract

While right ventricular (RV) function and size are important clinical markers in several cardiac conditions, the assessment of RV function by two-dimensional (2D) echocardiography remains challenging, due to the complexity of RV geometry. We therefore sought to compare an easily-measured parameter, peak systolic velocity of tricuspid annulus (TAPSV) obtained by tissue Doppler imaging (TDI), to right ventricular ejection fraction (RVEF) measured by real time three-dimensional echocardiography (RT3DE) and to explore what TAPSV cutoff values would be useful in detecting global RV dysfunction. We enrolled 20 patients affected by primary pulmonary hypertension and 30 consecutive healthy volunteers, who underwent transthoracic echocardiography, RT3DE and tissue Doppler evaluation. TAPSV had a statistically significant correlation with RVEF (r = 0.66, P < 0.001). With RV dysfunction defined as RVEF <40%, a TAPSV cutoff value of 9.5 cm/sec yielded the best compromise between sensitivity, specificity, and positive predictive value and negative predictive value. In conclusion, a TAPSV cutoff value of 9.5 cm/sec yields significantly high sensitivity and specificity and appears to be a valid compromise in detecting RV dysfunction, TAPSV values however are not useful in evaluating the severity of RV dysfunction.

Entities:  

Mesh:

Year:  2008        PMID: 18307442     DOI: 10.1111/j.1540-8175.2007.00587.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  6 in total

1.  Right ventricular function in late-onset Pompe disease.

Authors:  Abdallah Fayssoil; Olivier Nardi; Djillali Annane; David Orlikowski
Journal:  J Clin Monit Comput       Date:  2014-01-14       Impact factor: 2.502

2.  Relationship between echocardiographic and magnetic resonance derived measures of right ventricular size and function in patients with pulmonary hypertension.

Authors:  Hadas Shiran; Roham T Zamanian; Michael V McConnell; David H Liang; Rajesh Dash; Shahriar Heidary; Naga Lakshmi Sudini; Joseph C Wu; Francois Haddad; Phillip C Yang
Journal:  J Am Soc Echocardiogr       Date:  2014-01-18       Impact factor: 5.251

3.  New Echocardiographic Tehniques in Pulmonary Arterial Hypertension vs. Right Heart Catheterization - A Pilot Study.

Authors:  Tudor Constantinescu; Stefania Lucia Magda; Rodica Niculescu; Raluca Ileana Mincu; Dragos Zaharia; Claudia Lucia Toma; Mircea Cinteza; Miron Alexandru Bogdan
Journal:  Maedica (Buchar)       Date:  2013-06

Review 4.  Echocardiography in pediatric pulmonary hypertension.

Authors:  Pei-Ni Jone; D Dunbar Ivy
Journal:  Front Pediatr       Date:  2014-11-12       Impact factor: 3.418

5.  The effect of levosimendan on right ventricular function in patients with heart dysfunction: a systematic review and meta-analysis.

Authors:  Yaoshi Hu; Zhe Wei; Chaoyong Zhang; Chuanghong Lu; Zhiyu Zeng
Journal:  Sci Rep       Date:  2021-12-16       Impact factor: 4.379

6.  Echocardiographic parameters in patients with pulmonary arterial hypertension: correlations with right ventricular ejection fraction derived from cardiac magnetic resonance and hemodynamics.

Authors:  Tao Yang; Yu Liang; Yan Zhang; Qing Gu; Guo Chen; Xin-Hai Ni; Xiu-Zhang Lv; Zhi-Hong Liu; Chang-Ming Xiong; Jian-Guo He
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.